期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 907, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2021.174264
关键词
Dengue fever; SIRT2; Tenovin-1; Sirtuins
资金
- Natural Science Foundation of Guangdong Province, China [81603118, 81700854]
The new drug tenovin-1 shows promising potential in treating dengue virus infection by significantly inhibiting viral replication and inflammatory response. By targeting SIRT2, tenovin-1 exerts its antiviral effects with specificity.
Dengue fever is a common arbovirus disease, which has been spread to the entire tropical world. At present, effective drugs for the treatment of dengue fever have not yet appeared, and the dengue vaccines studied in various countries have also experienced severe adverse reactions. Thus it is urgent to find new chemicals against dengue virus. Now we found Sirtuins (SIRTs) were increased during dengue virus infection and tenovin-1, a SIRT1/2 inhibitor, showed an impressive antiviral ability in vitro. In BHK-21 cells, tenovin-1 inhibited the replication of DENV2 with an EC50 at 3.41 +/- 1.10 mu M, also inhibited other three types of dengue viruses with EC50 at 0.97 +/- 1.11 mu M, 1.81 +/- 1.08 mu M, 3.81 +/- 1.34 mu M respectively. Moreover, the cytopathic effect-induced DENV2 was largely improved by tenovin-1 treatment and the release of progeny viruses was inhibited by tenovin-1 treatment. At the same time, the viral protein level and mRNA level were decreased with tenovin-1 treatment after dengue virus infection. From the drug-addition assay, the tenovin-1 played its antiviral after viral infection, which indicated tenovin-1 was not a microbicide. Apart from its antiviral effect, tenovin-1 inhibited the inflammatory response caused by DENV2, reducing the release of inflammatory factors during viral infection. The antiviral effect of tenovin-1 was abrogated with SIRT agonist or SIRT2 knockdown treatment, which indicated the effect of tenovin-1 was on-target. In conclusion, tenovin-1 was proved to be a promising compound against flavivirus infection through SIRT2, which should be pay more attention for further study.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据